Navigation Links
Newly appreciated membrane estrogen receptor important therapeutic target for breast cancer
Date:7/1/2009

PROVIDENCE, RI New research at Rhode Island Hospital has uncovered the biological effects of a novel membrane estrogen receptor, a finding that has potential implications for hormonal therapy for breast cancer. The study is published in the July edition of the journal Molecular Endocrinology. This new study by Edward Filardo, MD, and his research team further supports earlier published work by the group that linked the transmembrane receptor, GPR30/GPER-1, to specific estrogen binding, rapid estrogen signaling and breast cancer metastasis. "What is exciting about this new work," says Filardo, "is that it provides some insight into the influence of GPR30 at the cellular level. It shows that estrogen action through GPR30 allows for breast tumor cell survival, and not breast tumor cell proliferation." Prior studies by Filardo's group showed that estrogen acts through GPR30 to promote the rapid release of preformed growth factors that are tethered to the surface of breast cancer cells. Their latest study was conducted in an effort to better understand the mechanism by which GPR30 triggered the release of epidermal growth factor (EGF) polypeptides from the surface of breast cancer cells.

The investigator's found that the "growth factors" did not promote cellular growth, which by itself is not a novel finding. It has long been appreciated that EGF-related factors are also important in other cellular activities such as cellular survival. Filardo and the research team, however, found that estrogen action through GPR30 had a more profound effect on tumor cell survival. They found that GPR30 promoted the assembly of what is called a "provisional extracellular matrix" -- a crucial event in cellular survival. More specifically, they found that release of growth factor by GPR30 required the activation of a latent adhesion receptor (known as integrin 51).

Filardo says, "Activation of integrin 51 by GPR30 is a signif
'/>"/>

Contact: Nancy Cawley Jean
njean@lifespan.org
Lifespan
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Newly Launched Free Choice Foundation Attempts Rescue of Japan's Private Heath Care Network
2. Dr. Juan Carlos Cobo Newly-Elected Chair of the Mutual Protection Trust Board of Trustees
3. Missouri Doctor, David Barbe, M.D., Newly Elected to AMA Board of Trustees
4. kidneySPA Introduces A Revolutionary Approach To Dialysis Treatment Newly Opened Facility Combines "Medical" Expertise with "Spa-Like" Experience
5. Inventor of Newly Available Vimpat(R) (lacosamide) C-V Meets a Woman Who Experienced Greater Seizure Control With Use of This New Antiepileptic Drug
6. Newly Identified Compounds May Inhibit Strep Infection
7. Now we know what blocks the effects of a newly developed anticancer therapy
8. Brockton Mayor, James E. Harrington Calls Press Conference to Unveil Newly Adopted Auto Emissions Technology Acquired With Federal Stimulus Money
9. MAXANT Launches MediPort 3000, The Next-Generation of All-In-One Workstations, on Its Newly Designed Website
10. Discount Medical Supplies Superstore Announces Newly Updated Website: Easy Shopping, Hundreds of Top Brands
11. Walnuts and Fish Protect Against Heart Disease in Different Ways, According to Newly Published Loma Linda University Research

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...les may reduce future disease burden, researchers ... -- Encouraging city dwellers to walk and bicycle ...lic health benefits than increased used of low-emi...The study compared the projected health effects in...s for London, England, and Delhi, India: business...
(Date:11/27/2009)...cturers who use medical load cells at the heart of...bringing in technology partner Flintec early in th... medical manufacturers are calling in Flintec load...ts, ensuring that progress will not be constrained...ted technology. , (PRWEB)...
(Date:11/26/2009)...ybdate (TM) has been shown in studies to be effect...caused by an overload of copper, and certain metas...wever, is known about how the drug works at the mo... University researchers now has provided an invalu...ound to copper-loaded metallochaperones. The drug ...
(Date:11/26/2009)... Dental (RTDental), a leading dental group practic...xpansion of its services to include LUMINEERS by a... , Durham, NC (PRWEB) --...hat Dr. Doug Macmillan, an experienced LUMINEERS ...d training seminar. RTDental’s ability to f...
(Date:11/25/2009)...-FirstCall/-- OnyxPharmaceuticals,Inc.(Nasdaq: ON...reventsinDecember: ,, ASHBriefing ,, D...ipalinvestigatorswilldiscussdatapresentationssurro...emyeloma,asfeaturedatthe51stAmericanSocietyofHemat...A.Theteleconferencewillbeginat9:00a.m.CT/10:00a.m....
Breaking Medicine News(10 mins):Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2
... Home delivery of Dechra,s full product line, incl... BURNIE, Md., Feb. 13 VetCentric, Inc., the natio...prescription medications and veterinary therapeuti...ch to veterinarians and pet owners by utilizing Ve...
... AFGE Applauds Senator Rockefeller and Representat...ASHINGTON, Feb. 13 The American Federation of Gov...ts of Senator Jay Rockefeller (D-WV), member of th...to amend Section 7422 of Title 38, expanding the w...
... New and emerging biomedical approaches to HIV/AI...sium on February 24 sponsored by the UCSF-Gladston... AIDS Research (CFAR) and the UCSF Center for AIDS...e a timely overview of the most promising advances...
... SAN DIEGO, Feb. 13 SpectraScience, Inc. (OTC Bul...ce company, today announced that it has establishe...rus markets through M.S. Jacovides Hellas S.A . , ... Marketing, commented, "We are pleased to add anot...
... Full Sense(TM) Device completes successful clinic...entinel Group announced the completion of the firs...as conducted at Galenia Hospital in Cancun, Mexico...ed for 6 weeks to evaluate weight loss, satiety (l...
... CHICAGO, Feb. 13 The Female Health Company (NYSE...purchase program has been expanded to 3,000,000 sh...gram was initiated in January 2007 to repurchase u...d until December 31, 2009. Through January 31, 200...
Other Medicine News:Health News:VetCentric Partners with Dechra Veterinary Products 2Health News:Veterans' Affairs Employee Union Urges Congress to Strengthen Collective Bargaining Rights at VA Hospitals 2Health News:UCSF symposium considers biomedical approaches to HIV/AIDS prevention 2Health News:SpectraScience Secures Distribution for WavSTAT(R) Cancer Diagnosis System in Greece & Cyprus 2Health News:SpectraScience Secures Distribution for WavSTAT(R) Cancer Diagnosis System in Greece & Cyprus 3Health News:Weight Loss Without Hunger! 2Health News:The Female Health Company Expands and Extends Its Stock Repurchase Program 2Health News:The Female Health Company Expands and Extends Its Stock Repurchase Program 3
(Date:11/25/2009)...,, SANDIEGO,Nov.25/PRNewswire-FirstCall/--NuVas...edondevelopingproductsforminimallydisruptivesurgic...staconferencecallonMonday,November30,2009,at5:30p....tissuesrelativetoreimbursementfortheCompany,sprodu...shortquestionandanswersession.Thedial-innumbersare...
(Date:11/25/2009)...,, NEWYORK,Nov.25/PRNewswire/--Reportlinker.com...itscatalogue: ,, IntranasalDrugDelivery-USMark.../p0164267/Intranasal-Drug-Delivery---US-Market-Tre...erymarketiswitnessinganexpansionoftherapeuticappli...icdrugstothedeliveryofsystemictherapeuticdrugs.The...
(Date:11/25/2009)...,, MOUNTAINVIEW,Calif.,Nov.25/PRNewswire/-- Ch...caldatafromtheCompany,sPROTECT-1(theProspectiveRan...ofTraficet-EN(TM)(CCX282-B)inpatientswithmoderate-...ywithafavorablesafetyandtolerabilityprofile.Thestu...tionofdiseaseseverityasdefinedasa70-pointdecreasei...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Consumer Driven Health Plans Surpass HMOs in Popularity With Employees 54697 1Consumer Driven Health Plans Surpass HMOs in Popularity With Employees 54697 2Consumer Driven Health Plans Surpass HMOs in Popularity With Employees 54697 3Consumer Driven Health Plans Surpass HMOs in Popularity With Employees 54697 4Consumer Driven Health Plans Surpass HMOs in Popularity With Employees 54697 5U S District Court Rules Against Lilly Regarding Gemzar Patent 54695 1U S District Court Rules Against Lilly Regarding Gemzar Patent 54695 2U S District Court Rules Against Lilly Regarding Gemzar Patent 54695 3U S District Court Rules Against Lilly Regarding Gemzar Patent 54695 4Severe breathing disorders during sleep are associated with an increased risk of dying 9606 1Severe breathing disorders during sleep are associated with an increased risk of dying 9606 2
... Touch control panel with 3 charging wells. Availa...Blue and Cinnamon. Spring balanced refractor and s...ction for lifelong quality. Sealed hydraulic syste...ement. Chair back reclines manually to fully horiz...
...eveloped the patented HydroKeratome corneal cuttin...t and industry experts believe it will replace the...okeratome, currently used in the LASIK refractive ...Company has demonstrated that its proprietary tech...
2.5v Ophthalmoscope Set
3.5v Coaxial Ophthalmoscope Set
Medicine Products: